Measurements were made of the nature and levels of pi as minogen activator in human tears using, as a model of inflammation, patients undergoing cataract surgery. Tis sue plasminogen activator (t-PA) but not urokinase plas minogen activator (u-PA) was found in tears. A wide variation in the range of t-PA in pre-operative tears was found. In those patients not receiving per-operative sub conjunctival betamethasone a significant rise in t-PA was found in tears on the first post-operative day over pre operative levels. A significant fall was noted in those receiving per-operative subconjunctival betamethasone.
Plasmin is a potent protease involved in fibrinolysis and in situations of tissue remodelling and neoplasia. It is formed by the action of plasminogen activator (PA) on plas minogen (PIg), an abundant plasma protein.! There are two major endogenous PAs: tissue plasminogen activator (t-PA) of relative molecular mass about 68 000 (Mr 68k), and urokinase (u-PA) of Mr 54k and 34k in its higher and lower molecular weight forms (HMW and LMW) respectively.
PA-Plasmin System
Tissue plasminogen activator (t-PA) is essential to vas cular fibrinolysis. It binds to fibrin which stimulates its plasminogen activating activity and it is produced and released by vascular endothelial cells? Urokinase (UK or u-PA) does not bind to fibrin and is concerned with tissue remodelling and cell migration. It is synthesised as a single chain inactive proenzyme, pro-urokinase (pro-UK), by a variety of cells including epitheliaV fibroblastic and inflammatory cells. Many cells bind pro-UK and HMW-UK without loss of PA activity and with relative protection from the action of PA inhibitors. Although binding of u-PA to fibrin does not occur, fibrin will stimu late u-PA induced thrombolysis.
PA-Plasmin Inhibitors
The action of plasmin is controlled by naturally occurring Eye (1992) 6, [653] [654] [655] [656] [657] [658] inhibitors; these include a2-antiplasmin a specific plas min inhibitor, a2-macroglobulin, a non-specific inhibitor of plasmin, and a series of specific inhibitors of plas minogen activators such as plasminogen activator inhibi tor-I and -2 (PAI-I and PAI-2) and protease nexin, a cell surface inhibitor, which have differing affinities for t-PA and u-PA (e.g. PAI-I is a more potent inhibitor of t-PA than u-PA whereas PAI-2 is more effective against u-PA). PAI-l and PAI-2 have little effect on plasmin activity.!
Ti ssue Distribution
Immunoreactive t-PA is widely distributed in ocular tis sues, including the corneal endothelium and epithelium, the conjunctiva, the trabecular meshwork, lens epithe lium, peripheral vitreous, inner retina, and all vascular endothelia. 4 The concentration in human aqueous humour is low,5.6 while it is present both in the tears and in the lac rimal fluid.
Roles proposed for ocular PA have included remodell ing (lens epithelium), regulation of the resistance to aque ous outflow (trabecular meshwork) and maintenance of canalicular patency (tears). The potential therapeutic value of fibrinolytic agents has been explored in the treat ment of hyphaema, vitreous haemorrhage and retinal vas cular occlusion.
Berman et az.7 proposed that PA may play an important part in retarded epithelial resurfacing and stromal melting after alkali bums. Resurfacing of the cornea after a corneal abrasion is associated with the appearance of fibrin and fibronectin (FN) at the stromal surface. The cell-binding domain of the FN offers an essential scaffold to the ingrowing epithelium, which affords attachment to the underlying basal lamina. Blocking epithelial binding sites with synthetic FN cell-binding domain fragments8 blocks pigment epithelial binding sites. 9 Berman has proposed that some indolent healing may be due to excessive tear plasmin activity, acting both by digesting FN 12 have demonstrated that PA is present in normal cornea and cultured corneal epi thelial cells and that it is in a latent form (proactivator), whereas alkali-burned corneae are rich in active PA. Plas minogen activator has been shown to stimulate latent col lagenase production in fibroblast cultures and organ-cultured alkali-burned corneal stroma. Plasmin can generate collagenase, which is recognised to have an important role in stromal destruction after alkali burns. The appearance of active collagenase in alkali-burned cor nea correlates with the appearance of high levels of active PA in that tissue.
With this background we looked at the PA-plasmin system of human tears using routine extracapsular cataract surgery with intraocular lens implantation as a model for ocular injury. This had the attraction of providing an inflammatory model with a relatively standardised time course in which inflammatory events such as vasodilata tion, increased vascular permeability and the outpouring of polymorphonuclear cells into tears were known to occur. 13 We were interested in the effects of glucocorti coids and of limbal versus corneal section as an operative procedure on the PA-plasmin system.
METHODS AND MATERIALS

Chromogenic Assay of Plasminogen Activator
Plasminogen activator was measured by a chromogenic assay.14 Tear samples are taken using a 10 �l glass capil lary tube in contact with the inferior marginal tear-strip, at the junction of the lateral quarter and medial three quarters of the lower eyelid. About 1 0 �l of tears were taken up to a pre-set mark and the tear sample was immediately trans ferred to a microcentrifuge tube (Ependorff), then frozen and stored at -20°C. Samples were assayed in microtitre plates by a plasminogen-coupled chromogenic substrate (S-2251; Val-Leu-Lys-pNA) method in the presence of cyanogen bromide-fragmented fibrinogen as stimulator. The absorbance of the generated p-nitroanilide was measured spectrophotometrically using a microtitre plate reader set at 405 nm (Multiscan MC-Flow Laboratories). By comparing the absorbance of the samples with a stan dard curve of human t-PA, the t-PA-like activity was derived.
Zymography
To determine the PA species, SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out followed by fibrin enzymography.15.16 Tear samples were electropho resed with t-PA and u-PA standards for 5 hours at 30 milli amps per gel. Following electrophoresis the gel was soaked in 2.5% v/v Triton X-IOO for 2 hours, then placed on a fibrin-agarose composite bonded to Gel-Bond and incubated at 22°C for 16-24 hours. Active PA was indi cated by clear lysis of the opaque fibrin background and a permanent record was made by drying and staining the overlay with amido-black (Fig. 1 ). Molecular weight stan dards (Pharmacia Ltd.) run on the same gel were used to estimate the molecular weight of the active enyzmes and complexes.
Characterisation of PA
To confirm the identity of the PA found in tears, rabbit anti-human t-PA IgG was incorporated into the fibrin agarose overlays.
Identification of PA-Plasmin Inhibitors
To investigate the presence of PA-plasmin inhibitors, reverse fibrinolysis enzymography was performed.17 Fol lowing SDS-PAGE the gel was overlaid with a fibrin agarose film incorporating 0.2IU cm3 urokinase and incu bated at 22°C for 16-24 hours. The presence of inhibitor was seen in the overlay as areas of opaque fibrin against a lysed background. The undigested zones of fibrin were stained dark with amido-black (Fig. 2) . 
Detection of Plasminogen
The presence of plasminogen antigen in tears was demon strated by Ouchterlony immunodiffusion18 using rabbit anti-human plasminogen antisera. The presence of plasminogen and of plasminogen breakdown products or complexes was signified by single or double immuno precipitin lines of identity (Fig. 3) .
Patients
Tear samples were collected from 30 patients who under went routine extracapsular cataract extraction with pos terior chamber lens implantation. Samples were collected pre-operatively, and on the first and second post-operative days. In a few patients tears were collected after 2 and 6 weeks post-operatively. Patients were stratified to receive either no subcon junctival steroid at the end of surgery or 4 mg betametha sone. All patients received subconjunctival gentamicin 20 mg at the end of surgery. In each group some patients received limbal sections with a formix-based conjunctival flap, and some corneal sections. Of the 16 who received subconjunctival steroid, 6 patients (3 with limbal and 3 with corneal sections) received no topical steroid in the first 2 post-operative days while the remainder received betamethasone four times daily from day 1 (Fig. 4) .
RESULTS
Pre-operative samples (Table I) all contained PA activity. Zymography on pre-and post-operative tear samples demonstrated t-PA activity (Mr 68k) but not u-PA activity (Mr57k or 36k) (Fig. 1) . The presence of t-PA antigen was confirmed by zymography with t-PA antibodies in both pre-and post-operative tear samples. All fibrinolytic activity was completely inhibited by specific antibody to t-PA. In addition fibrinolytic activity to t-PA correspond ing to a higher molecular weight was also observed in some samples, which may represent a t-PA complex.
Repeated 10 �l sampling from a single conjunctival sac is associated with a fall in PA activity (Fig. 5) and, on an arbitrary basis, the first 10 �l sample was used in this study.
Data were further analysed for an effect of limbal versus corneal section on tear PA levels and for an effect of the introduction of topical betamethasone post-operatively in those patients not receiving per-operative steroids. The majority of corneal section patients who received no per operative steroid showed a rise in PA activity on the first post-operative day (Fig. 6 ) while those receiving per operative steroid showed a fall (Fig. 7) . This fall is signifi- In group A, the post-operative median tear PA activity fell on the first post-operative day. This fall is significant (p = 0.041). In group B, the post operative median tear PA activity rose on the first post-operative day. The rise is significant (p = 0.0031) using the Wilcoxon matched pairs signed ranks test. There was no significant difference in the PA values between the two groups pre-operatively (Mann-Whitney V-test). The median level of PA activity in normal pre-operative tears was 2.21 IV/cm3 (n = 29). cant (p = 0.041). Limbal section patients also showed a difference in post-operative PA activity between no steroid (Fig. 8) and steroid-treated groups (Fig. 9 ), but this is not statistically significant, the numbers in each group being small and the scatter of values wide.
Immunodiffusion studies confirm the presence of plas minogen in both pre-and post-operative tear samples, indicating that the substrate for plasmin formation is pres ent in both situations (Fig. 3) . Reverse zymography stud ies on pre-operative tear samples show the presence of an inhibitor to u-PA. This was, however, usually absent in post-operative (first day) tear samples, which may reflect the increased levels of activity in such samples. 
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Patients Fig. 7 . The diff erence between pre-operative (light columns) and post-operative (dark columns) tear PA activity (IV/cm 3 ) in the 9 corneal section patients who received per-operative sub conjunctival steroid. The mean PA level fell on the first post operative day. The collection and storage system used in this study was arrived at by trial and error. The tear volume available from individual patients varied, as did the reflex tearing that results from the collection procedure, though there are plentiful tears in the conjunctival sac of post-operative patients compared with pre-operative patients. Repeated 10 III sampling from a single conjunctival sac is associ ated with a fall in PA activity which is assumed to be due to a progressive dilution of the tears by PA-poor lacrimal fluid (Fig. 5) .
Earlier studies in which 10 III samples were stored dry in microwells at -20°C gave widely variable results, and this procedure was therefore not continued. There was considerable variation in PA values between patients and the factors responsible have not yet been fully explored. It is likely that they include patient variation, the effects of surface trauma during collection, reflex tearing and of loss of activity on transport, and storage or thawing of samples. Freeze-dried material kept for up to some months lost activity completely.
The PA assay system used here measures total PA-like activity (t-PA and u-PA) but does not take into account the possible presence of inhibitors or stimulators of the PA plasmin system. Evidence for the presence of inhibitor was found in tears of unoperated eyes by performing reverse zymography. The disappearance of inhibitor from a number of post-operative samples is of interest in sug gesting one mechanism by which PA-plasmin activity might be increased following the trauma of surgery. It is, however, perhaps surprising, since the increase in vascular permeability following surgery would be expected to release blood-borne natural inhibitors into the tear sac. Removal of inhibitor could imply a complexing of avail able inhibitor to substrate, such as plasmin, or dilution of tears by an inhibitor-poor lacrimal fluid.
On the basis of zymography with anti-t-PA antibody, the PA activity of pre-and post -operative tear samples was and Beebe found only u-PA in tears from normal and injured rabbit eyes. Hayashi and Sueishi,22 using fibrino lytic zymography, identified both t-PA and u-PA activity in normal human tears, giving values for t-PA of 5.2 ± 1.3 IU/cm3 and for u-PA of 2.8 ± 0.5 IU/cm3 (n = 6). These discrepancies are not resolved. In our zymographic studies, fibrinolytic zones were present in some samples at positions corresponding to a higher mol ecular weight than t-PA; this is assumed to be due to the presence of PA-complexes, as yet uncharacterised. The immunodiffusion studies detected material which reacted with antibody raised against plasminogen. This antibody cross-reacts with plasmin, but since plasmin has not been detected in normal tears it may be assumed that a 657 positive precipitation line signifies the presence of plas minogen. The precipitation lines in post-operative samples could be either plasminogen, plasmin or both. The specific form, or forms, in which PA is released at the surface of the eye in various conditions, including surgical trauma, is important in determining the site of plasmin for mation. Tissue PA would be expected to locate at the site of a wound or epithelial defect where fibrin is known to accumulate. This would have an important regulatory function in wound healing, facilitating cell movement and removal of extracellular matrix proteins.
The response to surgical trauma in the absence of steroid exposure was a significant rise in tear PA activity. Exposure to per-operative betamethasone resulted in a sig nificant fall in tear PA activity, an effect seen with the combined limbal section and corneal section patients, and also when the corneal section patients were considered alone (p = 0.041). Limbal section patients also appeared to have reduced PA activity with exposure to per-operative steroid, though the effect did not reach significance in this study, the numbers being small. Median pre-operative PA levels in the steroid and no-steroid groups differed, though the difference was not statistically significant.
The difference in tear PA activity between steroid treated and untreated eyes is of interest and has some sup port in other systems. Crutchley et al?3 demonstrated a decrease in extractable PA activity from cultured fibro blasts exposed to glucocorticoids, which was attributed to the production of PA inhibitor. If such an effect of steroids on the eye is confirmed, it would appear to act in an oppo site manner to the well-known effect of glucocorticoids in diminishing wound strength, since it would result in a con servation of extracellular matrix proteins and a diminished activation of collagenase. However, an effect of steroid could simply relate to the intensity of granulocyte invas ion of tears following surgery or to an action on the inhibi tory system. The finding of increased PA activity in tears after cataract extraction may have relevance in wound healing as excessive tear plasmin activity may cause FN to be digested resulting in possible retarded healing.7 Reduc tion in post-operative PA activity with the use of subcon junctival betamethasone may be beneficial to allow early wound healing.
